维普中文期刊产品整合服务
45篇 您的检索式:作者名="Elting LS"
    题名 作者 年代 出处 被引量
1Updated clinical practice guidelines for the prevention and treatment of mucosi- tis显示文摘Keefe DM Schubert MM Elting LS 2007Cancer2007,109,5:1
2An open trail of cefoperazone plus sulbactam for the treatment of fever in cancer patients 显示文摘Bodey GP Elting LS Narto J 1993J Antimicrob Chemother1993,32,1:1
3Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy显示文摘Cantor SB Elting LS Hudson DV Jr 2003Cancer2003,97,12:1
4The burdens of cancer therapy显示文摘Elting LS Cooksley C Chambers M 2003Cancer2003,98,7:1
5Updated clinical practice guidelines for the prevention and treatment of mucositis显示文摘Keefe DM Schubert MM Elting LS 2007Cancer2007,109,:1
6Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin- 11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy 显示文摘Cantor SB Elting LS Hudson DV Jr 2003Cancer2003,97,12:1
7Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors 显示文摘Elting LS Khardori N Bodey GP Fainstein V 1990Infect Control Hosp Epidemiol1990,11,3:1
8analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy显示文摘Cantor SB Elting LS Hudson DV 2003Cancer2003,97,12:1
9Updated clinical practice guidelines for the prevention and treatment of mucositis显示文摘Keefe DM Schubert MM Elting LS 2007Cancer2007,109,5:1
10Bisphosphonate-associated osteonecrosis:a long-term complication of bisphosphonate treatment显示文摘Migliorati CA Siegel MA Elting LS 0,,06:1
11Pharmaceco nomic analysis of oprelvekin (recombinant human in terleukin-ll) for secondary prophylaxis of thrombocy topenia in solid tumor patients receliveing chemothera py显示文摘Cantor SB Elting LS Hudson DW 2003Cancer2003,97,2:1
12Measuring chem- otherapy-induced nausea and emesis - Psychometric prop- erties of a quality of life questionnaire显示文摘Martin CG Rubenstein EB Elting LS 2003Cancer2003,98,3:1
13Outcomes and cost of deep venous throm bosis patients with cancer显示文摘Elting LS Escalante CP Cooksley C 2004Arch Intem Med2004,154,15:1
14Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general ontology practice显示文摘Elting LS Rubenstein EB Kurtin D 1998Cancer1998,83,12:1
15Factors influencing the volume - outcome relationship in gastrectomies: a population - based study 显示文摘Smith DL Elting LS Learn PA 2007Ann Surg Oncol2007,14,6:1
16Updated clinical practice guidelines for the prevention and treatment of mucositis 显示文摘Keefe DM Schubert MM Elting LS 2007Cancer2007,109,5:1
17Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia显示文摘Elting LS Lu C Escalante CP 0,,06:1
18Mucositis Study Section of the Multinational Association for Supportive Care in Cancer Perspectives on cancer therapy-induced mucosal injury:pathogenesis,measurement,epidemiology,and consequences for patients显示文摘Sonis ST Elting LS Keefe D 2004Cancer2004,100,:1
19Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology显示文摘Schiffer CA Anderson KC Bennett CL Bernstein S Elting LS Goldsmith M Goldstein M Hume H McCullough JJ McIntyre RE Powell BL Rainey JM Rowley SD Rebulla P Troner MB Wagnon AH American Society of Clinical Oncology 2001J Clin Oncol2001,19,5:1
20Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radio therapy with or without chemotherapy:demonstration of increased fre- quency,severity,resistance to palliation,and impact on quality of life 显示文摘Elting LS Keefe DM Sonis ST 2008Cancer2008,113,10:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费